Degos disease: Difference between revisions

Revision as of 11:02, 15 February 2025

A rare vasculopathy affecting the skin and internal organs

Degos disease, also known as malignant atrophic papulosis, is a rare vasculopathy characterized by distinctive skin lesions and potential involvement of internal organs. The disease is named after the French dermatologist Robert Degos, who first described it in 1941.

Clinical presentation

Degos disease typically presents with small, erythematous papules that evolve into porcelain-white atrophic scars with a surrounding telangiectatic rim. These lesions are most commonly found on the trunk and extremities. The disease can be divided into two forms: a benign cutaneous form and a systemic form that involves internal organs.

Cutaneous manifestations

Characteristic skin lesions of Degos disease

The cutaneous form of Degos disease is characterized by the presence of multiple papules that develop into atrophic scars. These lesions are pathognomonic and are often the first sign of the disease. The skin lesions are usually asymptomatic but can be cosmetically concerning for patients.

Systemic involvement

In the systemic form of Degos disease, internal organs such as the gastrointestinal tract, central nervous system, and cardiovascular system may be affected. This can lead to serious complications, including bowel perforation, stroke, and myocardial infarction. The systemic form is associated with a poorer prognosis compared to the cutaneous form.

Pathophysiology

The exact cause of Degos disease is unknown, but it is believed to be an autoimmune process that leads to occlusion of small and medium-sized blood vessels. This results in tissue ischemia and the characteristic skin and organ lesions. Histopathological examination of skin lesions reveals wedge-shaped dermal necrosis and a lymphocytic infiltrate.

Diagnosis

Diagnosis of Degos disease is primarily clinical, based on the characteristic skin lesions. A skin biopsy can confirm the diagnosis by demonstrating the typical histopathological features. Additional investigations may be required to assess for systemic involvement, including imaging studies and endoscopy.

Management

There is no cure for Degos disease, and treatment is primarily supportive. Management focuses on alleviating symptoms and preventing complications. Antiplatelet agents, anticoagulants, and immunosuppressive therapies have been used with varying success. Regular monitoring for systemic involvement is crucial.

Prognosis

The prognosis of Degos disease varies depending on the extent of systemic involvement. The cutaneous form generally has a benign course, while the systemic form can be life-threatening due to complications such as bowel perforation and stroke.

Related pages

@@ Line 1: / Line 1: @@
-'''Degos Disease''', also known as '''Malignant Atrophic Papulosis''', is a rare, chronic, vascular occlusive disorder that affects the skin, gastrointestinal tract, and, in some cases, multiple internal organs. The disease is characterized by the appearance of small, porcelain-white papules with a red rim, primarily on the trunk and upper extremities. These lesions represent infarcts of the skin due to the occlusion of small and medium-sized arteries. The exact cause of Degos Disease remains unknown, and it is classified into two forms: a benign form that affects only the skin, and a systemic form that involves internal organs and can be potentially life-threatening.
+{{Short description|A rare vasculopathy affecting the skin and internal organs}}
+{{Use dmy dates|date=October 2023}}
-==Symptoms and Signs==
+'''Degos disease''', also known as '''malignant atrophic papulosis''', is a rare [[vasculopathy]] characterized by distinctive skin lesions and potential involvement of internal organs. The disease is named after the French dermatologist [[Robert Degos]], who first described it in 1941.
-The initial presentation of Degos Disease typically involves the skin, where patients develop distinctive lesions that are small, round, and white with a telangiectatic rim. These lesions may appear over the trunk, arms, and occasionally on the face and scalp. In the systemic form of the disease, symptoms can vary widely depending on the organs involved but may include abdominal pain, diarrhea, weight loss, neurological symptoms (such as headaches, seizures, or sensory deficits), and cardiovascular symptoms.
+==Clinical presentation==
+Degos disease typically presents with small, erythematous papules that evolve into porcelain-white atrophic scars with a surrounding telangiectatic rim. These lesions are most commonly found on the trunk and extremities. The disease can be divided into two forms: a benign cutaneous form and a systemic form that involves internal organs.
+===Cutaneous manifestations===
+[[File:Degos-disease.jpg|thumb|right|Characteristic skin lesions of Degos disease]]
+The cutaneous form of Degos disease is characterized by the presence of multiple papules that develop into atrophic scars. These lesions are pathognomonic and are often the first sign of the disease. The skin lesions are usually asymptomatic but can be cosmetically concerning for patients.
+===Systemic involvement===
+In the systemic form of Degos disease, internal organs such as the gastrointestinal tract, central nervous system, and cardiovascular system may be affected. This can lead to serious complications, including bowel perforation, stroke, and myocardial infarction. The systemic form is associated with a poorer prognosis compared to the cutaneous form.
 ==Pathophysiology==
-The pathogenesis of Degos Disease is not fully understood, but it is believed to involve a combination of genetic predisposition and immune-mediated responses that lead to endothelial cell damage and thrombosis within small and medium-sized arteries. This results in tissue infarction and the characteristic lesions of the disease.
+The exact cause of Degos disease is unknown, but it is believed to be an [[autoimmune]] process that leads to occlusion of small and medium-sized blood vessels. This results in tissue ischemia and the characteristic skin and organ lesions. Histopathological examination of skin lesions reveals wedge-shaped dermal necrosis and a lymphocytic infiltrate.
 ==Diagnosis==
-Diagnosis of Degos Disease is primarily based on clinical presentation and histopathological examination of the lesions. Biopsy of a skin lesion typically shows wedge-shaped areas of ischemic necrosis and occlusive endovascular changes. Imaging studies and endoscopy may be used to assess internal organ involvement in systemic cases.
+Diagnosis of Degos disease is primarily clinical, based on the characteristic skin lesions. A skin biopsy can confirm the diagnosis by demonstrating the typical histopathological features. Additional investigations may be required to assess for systemic involvement, including imaging studies and endoscopy.
-==Treatment==
+==Management==
-There is no cure for Degos Disease, and treatment is largely supportive and aimed at managing symptoms. Antiplatelet agents and anticoagulants may be used to prevent thrombosis. Immunosuppressive therapy has been tried in some cases with variable success. The management of systemic involvement requires a multidisciplinary approach, addressing specific organ system complications as they arise.
+There is no cure for Degos disease, and treatment is primarily supportive. Management focuses on alleviating symptoms and preventing complications. Antiplatelet agents, anticoagulants, and immunosuppressive therapies have been used with varying success. Regular monitoring for systemic involvement is crucial.
 ==Prognosis==
-The prognosis of Degos Disease varies. The benign cutaneous form may persist for years without significant progression, while the systemic form can lead to severe complications and is associated with a higher mortality rate, particularly if major organs are involved.
+The prognosis of Degos disease varies depending on the extent of systemic involvement. The cutaneous form generally has a benign course, while the systemic form can be life-threatening due to complications such as bowel perforation and stroke.
-==Epidemiology==
+==Related pages==
-Degos Disease is extremely rare, with only a few hundred cases reported in the medical literature. It can occur at any age but most commonly affects young adults. There is no known gender or racial predilection.
+* [[Vasculitis]]
+* [[Autoimmune disease]]
-==History==
+* [[Dermatology]]
-Degos Disease was first described in 1942 by Robert Degos, a French dermatologist. Since its initial description, the understanding of the disease has evolved, particularly regarding its systemic implications.
+[[Category:Dermatology]]
 [[Category:Rare diseases]]
-[[Category:Vascular diseases]]
+[[Category:Autoimmune diseases]]
-[[Category:Dermatological conditions]]
-[[Category:Systemic diseases]]
-{{Medicine-stub}}